Biotech

All Articles

Praxis epilepsy medication decreases seizures in stage 2 litigation

.Practice Preciseness Medicines has racked up one more midphase gain in epilepsy this year, along wi...

Three officers resign as Dyne blog posts combined information for DMD candidate

.After getting away from a scientific grip numerous years back, Dyne Rehab has revealed brand-new st...

Arrowhead fires off period 3 records in unusual metabolic condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its give in front of a possible face-off with Ionis...

Pfizer, Valneva show lyme illness try reliable for 2nd booster

.Pfizer and Valneva might possess concerning pair of more years to hang around before they create th...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a talk with Ayla Ellison, Strong Biotech Managing Editor as well as Michelle Benz a...

New data demonstrate how Bayer's asundexian neglected to prevent strokes

.Bayer put on hold the period 3 trial for its own factor XIa prevention asundexian late in 2014 afte...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still set on taking its a number of sclerosis (MS) med tolebrutinib to the FDA, managers ...

Galapagos' stock up as fund presents intent to shape its development

.Galapagos is coming under additional pressure from clients. Having actually built a 9.9% risk in Ga...

Cell- focused Sana scoops very first CSO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and a...

Allist settles Jacobio $21M, landing task in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually gotten on its own a starring role in China's KRAS mark...